Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Utilization and Treatment Costs of Tumor Necrosis Factor Inhibitors After the Introduction of Biosimilar Infliximab in the United States.

Literature DB >> 31943866

Utilization and Treatment Costs of Tumor Necrosis Factor Inhibitors After the Introduction of Biosimilar Infliximab in the United States.

Seoyoung C Kim¹, Ameet Sarpatwari¹, Joan E Landon¹, Rishi J Desai².

Abstract

Entities: Chemical Disease Gene

Year: 2020 PMID： 31943866 DOI： 10.1002/art.41201

Source DB: PubMed Journal: Arthritis Rheumatol ISSN： 2326-5191 Impact factor: 10.995

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. Uptake of Biosimilars and Its Economic Implication for the Treatment of Patients with Rheumatoid Arthritis in Korea.

Authors: Soo Kyung Cho; Sun Young Jung; Hyoungyoung Kim; Yeo Jin Song; Kyungeun Lee; Yoon Kyoung Sung
Journal: J Korean Med Sci Date: 2021-05-24 Impact factor: 2.153

1 in total